Permissive hypercapnia for severe acute respiratory distress syndrome in immunocompromised children: A single center

Hans Fuchs1, Nicola Rossmann2, Manuel B Schmid3

  • 1Center for Pediatrics, Department of Neonatology and Pediatric Intensive Care, Medical Center - Albert Ludwig University of Freiburg, Faculty of Medicine, Freiburg, Germany.

Plos One
|June 21, 2017
PubMed

Insights

Controlled hypoventilation with high carbon dioxide levels (hypercapnia) can improve survival in immunocompromised children with acute respiratory distress syndrome (ARDS). This strategy, allowing lower lung pressures, was well-tolerated and showed promising results in a pediatric intensive care unit (PICU) cohort.

Area of Science:

  • Pediatric Critical Care Medicine
  • Respiratory Physiology
  • Mechanical Ventilation

Background:

  • Controlled hypoventilation accepting hypercapnia is proposed to mitigate ventilator-induced lung injury.
  • Immunocompromised children with acute respiratory distress syndrome (ARDS) face significant mortality.
  • The study investigated a strategy of progressively increasing carbon dioxide (PCO2) targets in these high-risk children.

Purpose of the Study:

  • To evaluate the outcomes of immunocompromised children with ARDS managed with a ventilation strategy allowing severe hypercapnia.
  • To assess the feasibility and safety of stepwise increasing PCO2 targets up to 140 mm Hg in this vulnerable population.

Main Methods:

  • Retrospective analysis of a cohort of children with oncologic disease or post-stem cell transplantation experiencing severe respiratory failure.
  • Comparison with a historical control group.
  • In a subgroup, PCO2 targets were stepwise increased, with outcomes meticulously recorded.

Main Results:

  • Overall survival in the PICU was 75% for children requiring invasive mechanical ventilation >24h.
  • In a subgroup (n=38) with high ventilator needs, a stepwise increase in PCO2 targets was implemented.
  • Survival in immunocompromised children on mechanical ventilation >24h increased from 32% (historical) to 48% with the new strategy.
  • Severe pulmonary hypertension occurred in 2 patients; no cerebral edema was observed.
  • Long-term follow-up in 15 patients showed 10 survived without neurological sequelae.

Conclusions:

  • A ventilation strategy accepting very high PCO2 levels is feasible and potentially beneficial in children.
  • Severe hypercapnia was well-tolerated, with no observed severe side effects.
  • This approach may improve survival rates for immunocompromised children with severe ARDS.
Abstract

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.0K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.2K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
552
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
623
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
1.9K